ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients

Desitin

Status: Completed

Conditions: Epilepsy

Study type: Observational

Funder types: Industry

Identifiers

NCT01086501

OXC-044/K

Details and patient eligibility

About

The aim of the observational study is to investigate the safety of oxcarbazepine extended release (ER) during long-term therapy in epileptic patients. In addition, quality of life parameters should be documented if assessed.

Enrollment: 225 patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with focal epileptic seizures with or without secondary generalised tonic-clonic seizures
• mono- or combination therapy
• male and female from the age of 6

Exclusion criteria

• hypersensitivity to oxcarbazepine MR or one of its excipients